Quick Takeaways
- Adage Capital Management, L.P. filed SCHEDULE 13G for Forte Biosciences, Inc. Common Stock, par value $0.001 per share (FBRX).
- Disclosed ownership: 6.8%.
- Date of event: 31 Mar 2026.
Quoteable Key Fact
"Adage Capital Management, L.P. disclosed 6.8% ownership in Forte Biosciences, Inc. Common Stock, par value $0.001 per share (FBRX) on 31 Mar 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Adage Capital Management, L.P. | 6.8% | 950,000 | 0 | 950,000 | /s/ Robert Atchinson | By: Adage Capital Partners, L.L.C., its General Partner, By: Robert Atchinson, its Managing Member | |
| Robert Atchinson | 6.8% | 950,000 | 0 | 950,000 | /s/ Robert Atchinson | Robert Atchinson, individually | |
| Phillip Gross | 6.8% | 950,000 | 0 | 950,000 | /s/ Phillip Gross | Phillip Gross, individually |